Furthermore, these studies suggest that immune modulation withmedications such as anti-IgE, anti-IL-4 and/or IL-13 monoclonal antibodies may be helpful in thetreatment of ABPA. The gene discussed is IL13; the disease is allergic bronchopulmonary aspergillosis.